Symposia

EU Biotech Act: Challenges and Chances for a Sustainable and Innovative Europe

Conference room: Forum 1

The EU Commission positively surprised the industry in spring 2024 by launching a counterpart to the US Biotech and Biomanufacturing Initiative. The EU Biotech Act is now due to come in  2026. What can this act do for the industry? What should the Act encompass in order warrant that Europe stays competitive with biotechnology?

Moderation

Dr. Gloria Gaupmann

Dr. Gloria Gaupmann

ROSA consult

Podium

Marianne Dessen-Mugniot

Marianne Dessen-Mugniot

AB Enzymes

Claudia Dierig

Claudia Dierig

Thermo Fisher Scientific

Hanna Freienstein

Hanna Freienstein

DG GROW

Prof. Dr. Andrea Wechsler

Prof. Dr. Andrea Wechsler

MEP, CDU